| 摘要 |
The present invention relates to a antithrombotic pharmaceutical composition comprising cilostazol and nitric oxide precursor and, more specifically, to an antithrombotic pharmaceutical composition which prescribes cilostazol as an antiplatelet agent with nitric oxide precursor having an extending function of endangium at an optimal ratio, thereby enhancing endangium action derived from intima than an existing cilostazol by a synergistic effect. |
